Dechra Pharmaceuticals (DPH) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Jun 2020 05:01 PM
RNS
Proposed Placing of Ordinary Shares
03 Jun 2020 04:58 PM
RNS
Trading Update
29 May 2020 10:22 AM
RNS
Total Voting Rights
30 Apr 2020 09:02 AM
RNS
Total Voting Rights
16 Apr 2020 07:00 AM
RNS
Completion of Acquisition
31 Mar 2020 03:14 PM
RNS
Total Voting Rights
30 Mar 2020 03:30 PM
RNS
Holding(s) in Company
27 Mar 2020 03:59 PM
RNS
Holding(s) in Company
18 Mar 2020 08:40 AM
RNS
Holding(s) in Company
17 Mar 2020 07:00 AM
RNS
Dechra acquires worldwide rights to Mirataz (R)
16 Mar 2020 08:41 AM
RNS
Block listing Interim Review
04 Mar 2020 03:34 PM
RNS
Holding(s) in Company
04 Mar 2020 10:11 AM
RNS
Block listing
28 Feb 2020 09:22 AM
RNS
Total Voting Rights
28 Feb 2020 07:00 AM
RNS
Appointment of new Non Executive Director
24 Feb 2020 07:00 AM
RNS
Half-year Report - six months ended 31.12.19
20 Feb 2020 05:14 PM
RNS
Holding(s) in Company
17 Feb 2020 10:11 AM
RNS
TR-1: Notification of Major Holdings
31 Jan 2020 10:57 AM
RNS
Total Voting Rights
16 Jan 2020 07:00 AM
RNS
Trading Update and Notice of Half Year Results
15 Jan 2020 08:49 AM
RNS
Holding(s) in Company
13 Jan 2020 03:44 PM
RNS
Holding(s) in Company
06 Jan 2020 07:00 AM
RNS
DPH acquire worldwide rights to Osurnia products
03 Jan 2020 04:32 PM
RNS
Holding(s) in Company
31 Dec 2019 07:00 AM
RNS
Total Voting Rights
19 Dec 2019 04:06 PM
RNS
TR-1: Notification of major share holdings
18 Dec 2019 04:16 PM
RNS
Private Placement
29 Nov 2019 09:30 AM
RNS
Total Voting Rights
25 Nov 2019 02:34 PM
RNS
Holding(s) in Company
20 Nov 2019 11:49 AM
RNS
Holding(s) in Company
12 Nov 2019 09:31 AM
RNS
Holding(s) in Company
06 Nov 2019 03:18 PM
RNS
Holding(s) in Company
06 Nov 2019 09:19 AM
RNS
Holding(s) in Company
31 Oct 2019 08:48 AM
RNS
Total Voting Rights
30 Oct 2019 07:00 AM
RNS
Appointment of Chief Financial Officer
18 Oct 2019 02:46 PM
RNS
Result of AGM 2019
18 Oct 2019 07:00 AM
RNS
AGM Trading Update
02 Oct 2019 03:42 PM
RNS
Holding(s) in Company
30 Sep 2019 09:49 AM
RNS
Total Voting Rights
23 Sep 2019 04:50 PM
RNS
Director/PDMR Shareholding
18 Sep 2019 09:32 AM
RNS
Director/PDMR Shareholdings
17 Sep 2019 10:03 AM
RNS
Annual Financial Report
16 Sep 2019 02:15 PM
RNS
Block listing Interim Review
11 Sep 2019 10:34 AM
RNS
Opening of its solar power plant in Croatia & CMD
06 Sep 2019 03:45 PM
RNS
Director/PDMR Shareholding
04 Sep 2019 01:32 PM
RNS
Availability of the 2019 Annual Report
02 Sep 2019 07:00 AM
RNS
Audited preliminary results - year ended 30.6.19
30 Aug 2019 12:55 PM
RNS
Additional Listing
29 Aug 2019 07:00 AM
RNS
Acquisition of Ampharmco LLC, USA
02 Aug 2019 07:30 AM
RNS
LICENSING AGREEMENT FOR SIGNIFICANT NOVEL PRODUCT

Dechra Pharmaceuticals is a global developer and marketor of eterinary pharmaceuticals and related products.

Based in Northwich, England. It was listed on the London Stock Exchange until it was acquired by EQT AB in January 2024.

Dechra share price was listed under the ticker DPH.

UK 100